PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.48%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
56.29%
Positive gross profit growth while MTDR is negative. John Neff would see a clear operational edge over the competitor.
100.00%
Positive EBIT growth while MTDR is negative. John Neff might see a substantial edge in operational management.
674.16%
Positive operating income growth while MTDR is negative. John Neff might view this as a competitive edge in operations.
293.08%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
295.08%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
293.44%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.54%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.75%
Dividend reduction while MTDR stands at 0.08%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-100.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-303.52%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
81.41%
10Y revenue/share CAGR under 50% of MTDR's 690.14%. Michael Burry would suspect a lasting competitive disadvantage.
220.27%
5Y revenue/share CAGR under 50% of MTDR's 1272.50%. Michael Burry would suspect a significant competitive gap or product weakness.
-38.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Negative 10Y OCF/share CAGR while MTDR stands at 1566.28%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Negative 5Y OCF/share CAGR while MTDR is at 362.73%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
112.39%
Net income/share CAGR at 50-75% of MTDR's 163.75%. Martin Whitman might question if the firm’s product or cost base lags behind.
107.03%
5Y net income/share CAGR at 75-90% of MTDR's 139.65%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-77.53%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-13.77%
Negative equity/share CAGR over 10 years while MTDR stands at 274.37%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
77.24%
Below 50% of MTDR's 204.54%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
77.03%
3Y equity/share CAGR at 75-90% of MTDR's 101.40%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
35.18%
Dividend/share CAGR of 35.18% while MTDR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
208.95%
Dividend/share CAGR of 208.95% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
19.48%
Below 50% of MTDR's 529.33%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-100.00%
Firm’s AR is declining while MTDR shows 2.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
272.06%
Asset growth above 1.5x MTDR's 1.79%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.50%
BV/share growth above 1.5x MTDR's 2.09%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.50%
We’re deleveraging while MTDR stands at 0.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.